Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2013-07-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2013-1940PMID 23861463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metastatic Medullary Thyroid Cancer Presenting with Elevated Levels of CA 19-9 and CA 125

  2011cited by this paper
• Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.

  2010cited by this paper
• Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta‐analysis

  2010cited by this paper
• Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.

  2008cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival

  2006cited by this paper
• Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

  2005cited by this paper
• Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.

  2005cited by this paper
• Blood group antigen expression in malignant tumors of the thryoid: a parallel between medullary and nonmedullary carcinomas

  2004influential reference
• Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

  2004cited by this paper
• Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis

  2000cited by this paper
• Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).

  2000cited by this paper
• Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970.

  1992cited by this paper
• Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.

  1991cited by this paper
• Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.

  1984cited by this paper
• Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease

  1984cited by this paper
• Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow‐up of medullary thyroid carcinoma

  1984cited by this paper
• Plasma catecholamines in hypertension and pheochromocytoma determined using ion-pair reversed-phase chromatography with amperometric detection: investigation of the separation mechanism and clinical methodology.

  1981cited by this paper
• Medullary thyroid carcinoma. Importance of serial serum calcitonin measurement

  1979cited by this paper

• Circulating Biomarkers of Thyroid Cancer: An Appraisal

  2025cites this paper
• Circulating Biomarkers in Medullary Thyroid Carcinoma: Bridging Laboratory Complexities and Clinical Application Through Algorithm Design

  2025influential citation
• Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update

  2024cites this paper
• Other markers of medullary thyroid cancer, not only calcitonin.

  2023cites this paper
• A Contemporary Review of the Treatment of Medullary Thyroid Carcinoma in the Era of New Drug Therapies.

  2023cites this paper
• Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor

  2021cites this paper
• Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors

  2020cites this paper
• CA19-9は甲状腺髄様癌の予後因子である可能性がある

  2020cites this paper
• CA19-9 May Be a Prognostic Factor for Medullary Thyroid Carcinoma

  2020cites this paper
• The tissue expression pattern of CA 19.9 is associated with oncological features in medullary thyroid carcinoma

  2020cites this paper
• CA19-9 as a Predictor of Worse Clinical Outcome in Medullary Thyroid Carcinoma

  2019cites this paper
• Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.

  2019influential citation
• Medullary Thyroid Cancer

  2019cites this paper
• Medullary Thyroid Cancer: Diagnosis and Non Surgical Management

  2018cites this paper
• مراْچ ، ريت 1334 Effects of Diesel Exhaust on Serum Levels of T3, T4 and

  2018cites this paper
• Circulating Mucins and Cytokeratins in Aggressive Thyroid Cancers

  2018cites this paper
• Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.

  2017influential citation
• Advances and controversies in the management of medullary thyroid carcinoma

  2017cites this paper
• Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis

  2017cites this paper
• Malignant Mucous Cells in a Thyroid Aspirate: Looking for a Source

  2016cites this paper
• Radionuclide Therapy of Thyroid Tumors

  2016cites this paper
• Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.

  2015cites this paper
• MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL.

  2015influential citation
• Evaluation of Serum Levels of CEA and CA 19-9 Tumor Markers in Healthy Individuals in Northwestern Iran

  2013cites this paper
• Uptodate view on diagnostics and treatment of medullary thyroid cancer

  2013cites this paper
• & Clinical

  year unknowninfluential citation